Paula I. González-Ericsson

Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data

Francesca Finotello, Clemens Mayer, Christina Plattner et al. · Genome Medicine · 2019 · 1.7K citations · Full text

Life Sciences, Immunology, Oncology +17

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

Luigi Formisano, Yao Lu, Alberto Servetto et al. · Nature Communications · 2019 · 419 citations · Full text

Medicine, Oncology, Pharmacology +17

DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer

Na Luo, Mellissa J. Nixon, Paula I. González-Ericsson et al. · Nature Communications · 2018 · 271 citations · Full text

Life Sciences, Immunology, Oncology +17

Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes

Brian D. Lehmann, Antonio Colaprico, Tiago C. Silva et al. · Nature Communications · 2021 · 260 citations · Full text

Medicine, Cancer Biology, Oncology +17

Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Valerie M. Jansen, Neil E. Bhola, Joshua A. Bauer et al. · Cancer Research · 2017 · 250 citations

Medicine, Oncology, Pharmacology +17